Cargando…

Medical abortion with mifepristone and home administration of misoprostol up to 63 days’ gestation

OBJECTIVE: To evaluate the acceptability and efficacy of medical abortion at home up to 63 days’ gestation without limits on travel distance to a registered institution. DESIGN: Observational prospective study. SETTING: Haukeland University Hospital between May 2006 and May 2009. POPULATION: A total...

Descripción completa

Detalles Bibliográficos
Autores principales:	Løkeland, Mette, Iversen, Ole Erik, Engeland, Anders, Økland, Ingrid, Bjørge, Line
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2014
Materias:	Gynecology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670695/ https://www.ncbi.nlm.nih.gov/pubmed/24766569 http://dx.doi.org/10.1111/aogs.12398

Ejemplares similares

Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013
por: Løkeland, Mette, et al.
Publicado: (2017)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
por: Wiebe, Ellen R, et al.
Publicado: (2020)

Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review
por: Abubeker, Ferid A., et al.
Publicado: (2020)

Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days’ gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial
por: Dragoman, Monica V., et al.
Publicado: (2016)

Early medical abortion with self‐administered low‐dose mifepristone in combination with misoprostol
por: Song, Li‐Ping, et al.
Publicado: (2018)

Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: Zhao, Xiaoying, et al.
Publicado: (2021)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
por: Shimels, Tariku, et al.
Publicado: (2023)

Retracted: Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy
por: Shah, Deepa, et al.
Publicado: (2018)

Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
por: Goldberg, Alisa B., et al.
Publicado: (2022)

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion
por: Chinery, Lester, et al.
Publicado: (2020)

A Retrospective Cost-Effectiveness Analysis of Mifepristone–Misoprostol Medical Abortions in the First Year at the Regina General Hospital
por: Hunter, Caitlin, et al.
Publicado: (2021)

Comparison of Intracervical Foley’s Catheter With Vaginal Misoprostol Versus Intravaginal Misoprostol Alone for Cervical Ripening and Induction of Labor
por: Kadu, Nivedita A, et al.
Publicado: (2023)

Outpatient Cervical Ripening With Misoprostol in Low-Risk Pregnancies
por: Roloff, Kristina, et al.
Publicado: (2021)

Comparison of two doses and two routes of administration of misoprostol after pre-treatment with mifepristone for early pregnancy termination
por: von Hertzen, Helena, et al.
Publicado: (2008)

Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss
por: Hamel, Charlotte C., et al.
Publicado: (2022)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Dutch GPs’ views on prescribing mifepristone and misoprostol: a mixed-methods study
por: Schellekens, Julia EAP, et al.
Publicado: (2022)

Factors Influencing the Duration of Termination of Pregnancy for Fetal Anomaly with Mifepristone in Combination with Misoprostol
por: Reischer, Theresa, et al.
Publicado: (2023)

Induction of Labor in Primigravid Term Pregnancy with Misoprostol or Dinoprostone: A Comparative Study
por: Arif, Rizwana, et al.
Publicado: (2019)

Comparison of Two Different Intervals of Misoprostol Administration in Second Trimester Abortions
por: Gupta, Anjali, et al.
Publicado: (2023)

Role of Combination OF Mifepristone and Misoprostol Verses Misoprostol alone in Induction of Labour in Late Intrauterin Fetal Death: A Prospective Study
por: Panda, Subrat, et al.
Publicado: (2013)

Treatment of Recurrent Cesarean Scar Pregnancy With Oral Mifepristone, Systemic Methotrexate, and Ultrasound-Guided Suction Dilation and Curettage
por: Masten, Megan, et al.
Publicado: (2023)

Efficacy and Safety of Carbetocin Versus Misoprostol in Cesarean Section: A Systematic Review and Meta-Analysis
por: Albazee, Ebraheem, et al.
Publicado: (2022)

Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial
por: Chu, Justin J, et al.
Publicado: (2020)

A Comparative Study of Sublingual Misoprostol Versus Intramuscular Oxytocin in the Active Management of Third Stage of Labor
por: Mishra, Shweta, et al.
Publicado: (2023)

The association between vaginal microbiota disorders and early missed abortion: A prospective study
por: Sun, Dan, et al.
Publicado: (2022)

Misadventure of an Unsafe Abortion
por: Hans, Punit, et al.
Publicado: (2022)

The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States
por: Mark, Alice, et al.
Publicado: (2021)

Medication Abortion Safety and Effectiveness With Misoprostol Alone
por: Jayaweera, Ruvani, et al.
Publicado: (2023)

Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial
por: Hamel, Charlotte, et al.
Publicado: (2021)

Comparison of Vaginal Dinoprostone Pessary With Transcervical Balloon Catheter Plus Vaginal Misoprostol for Pre-induction Cervical Ripening: A Randomized Trial
por: M, Kanagavarshani, et al.
Publicado: (2023)

Oral toxicity of isotretinoin, misoprostol, methotrexate, mifepristone and levonorgestrel as pregnancy category X medications in female mice
por: KIM, SEONG-KWAN, et al.
Publicado: (2015)

Mifepristone-misoprostol combination treatment for early pregnancy loss after embryo transfer: a case series
por: Esposito, Leah, et al.
Publicado: (2023)

Intravenous Carbetocin Versus Rectal Misoprostol for the Active Management of the Third Stage of Labor: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Albazee, Ebraheem, et al.
Publicado: (2022)

The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017)

Forensic Toxicological Aspects of Misoprostol Use in Pharmacological Abortions
por: Szpot, Paweł, et al.
Publicado: (2022)

Amniotic Fluid Embolism After First-Trimester Abortion
por: Panda, Subrat, et al.
Publicado: (2022)

Dispensing mifepristone for medical abortion in Canada: Pharmacists’ experiences of the first year
por: Zusman, Enav Z., et al.
Publicado: (2023)

Mifepristone Antagonization with Progesterone to Avert Medication Abortion: A Scoping Review
por: DeBeasi, Paul L. C.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b0b9d21dq1hji3414u9p0o9kgc